Home › Recently closed › 2026-10188
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program
Comment period closed: closed 117 days ago (Jun 22, 2026).
Read on FederalRegister.gov · Official PDF · Docket on Regulations.gov · Add to calendar (.ics)
Summary (from the Federal Register abstract)
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
- Document type
- Notice
- Federal Register document number
- 2026-10188
- Published
- May 21, 2026
- Action
- Notice.
- Docket
- FDA-2026-N-0746
- Comments posted on Regulations.gov (at last check)
- 0
- DATES section (from the document)
- Submit written comments (including recommendations) on the collection of information by June 22, 2026.
- Topics (auto-tagged)
- GMP / manufacturing
Source: Federal Register API, document 2026-10188. Federal Register text is a U.S. government work. Confirm dates in the official document; later documents may extend, reopen or correct them.